VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
UPXIUpexi, Inc.
$0.91$59M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

UPXI logoUpexi, Inc.(UPXI)Earnings, Financials & Key Ratios

UPXI•NASDAQ
Price updated Jun 19, 2026
SectorCommunication ServicesIndustryInternet ServicesSub-IndustryConsumer Apps and Utility Platforms
AboutUpexi, Inc. manufacture and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Clearwater, Florida.Show more
  • Revenue$16M-39.2%
  • EBITDA-$12M+37.5%
  • Net Income-$14M+42.2%
  • EPS (Diluted)-1.73+92.8%
  • Gross Margin68.74%+39.4%
  • EBITDA Margin-74.26%-2.8%
  • Operating Margin-79.06%+8.5%
  • Net Margin-86.55%+4.9%
  • ROE-28.33%+79.4%

UPXI Key Insights

Upexi, Inc. (UPXI) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 16.4%
  • ✓Trading at only 0.1x book value

✗Weaknesses

  • ✗Profits declining 20.5% over 5 years
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 10 (bottom 10%)
  • ✗Shares diluted 100.0% in last year
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when UPXI posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

UPXI Price & Volume

Upexi, Inc. (UPXI) stock price & volume — 10-year historical chart

Loading chart...

UPXI Growth Metrics

Upexi, Inc. (UPXI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years16.36%
3 Years-11.83%
TTM218.47%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-915.13%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM80.42%

Return on Capital

10 Years-37.81%
5 Years-30.24%
3 Years-47.08%
Last Year-24.49%

UPXI Recent Earnings

Upexi, Inc. (UPXI) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 2/12 qtrs (20%)●Beat Revenue 4/12 qtrs (33%)
Q2 2026Latest
May 12, 2026
Metric
Actual
Est
EPS
$1.67-735.0%
$0.20
Rev
$5M+57.1%
$3M
Q1 2026
Feb 10, 2026
Metric
Actual
Est
EPS
$1.24-1553.3%
$0.07
Rev
$3M-56.4%
$7M
Q4 2025
Nov 11, 2025
Metric
Actual
Est
EPS
$0.12-60.0%
$0.07
Rev
$9M-1.9%
$9M
Q2 2025
May 16, 2025
Metric
Actual
Est
EPS
$2.87-79.4%
$1.60
Rev
$3M-82.5%
$18M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 12, 2026
$1.67vs $0.20-735.0%
$5Mvs $3M+57.1%
Q1 2026Feb 10, 2026
$1.24vs $0.07-1553.3%
$3Mvs $7M-56.4%
Q4 2025Nov 11, 2025
$0.12vs $0.07-60.0%
$9Mvs $9M-1.9%
Q2 2025May 16, 2025
$2.87vs $1.60-79.4%
$3Mvs $18M-82.5%
Based on last 12 quarters of dataView full earnings history →

UPXI Peer Comparison

Upexi, Inc. (UPXI) competitors in Consumer Apps and Utility Platforms — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
NXRT logoNXRTNexPoint Residential Trust, Inc.Direct Competitor684.45M26.97-21.40-3.24%-12.67%-10.13%5.18
BYFC logoBYFCBroadway Financial CorporationProduct Competitor92.08M9.90-3.07-3.76%-39.3%-9.05%0.58
HIMS logoHIMSHims & Hers Health, Inc.Product Competitor7.79B35.4769.5559%-0.56%-2.48%2.34
OLPX logoOLPXOlaplex Holdings, Inc.Product Competitor1.38B2.05-147.480.07%-3.53%-1.7%0.40
SKIN logoSKINThe Beauty Health CompanyProduct Competitor85.9M0.66-4.14-10.02%-2.03%-9.41%6.20
PRPL logoPRPLPurple Innovation, Inc.Product Competitor46.54M0.43-0.89-3.93%-7.02%
NTRB logoNTRBNutriband Inc.Product Competitor35.86M2.95-1.14-4.83%-448.39%-112.6%0.03
YCBD logoYCBDcbdMD, Inc.Product Competitor7.56M0.72-0.66-1.5%-13.29%-33.59%107.70

Compare UPXI vs Peers

Upexi, Inc. (UPXI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NXRT

Most directly comparable listed peer for UPXI.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare UPXI against a more recognizable public peer.

Peer Set

Compare Top 5

vs NXRT, BYFC, HIMS, OLPX

UPXI Income Statement

Upexi, Inc. (UPXI) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricJun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Sales/Revenue
2.21M7.41M24.1M23.07M36.44M26M15.81M26.14M
Revenue Growth %
-235.72%225.04%-4.27%57.99%-28.65%-39.19%218.47%
Cost of Goods Sold
1.17M4.84M12.2M8.2M15.42M13.18M4.94M3.65M
COGS % of Revenue
53.07%65.33%50.62%35.53%42.32%50.68%31.26%-
Gross Profit
1.04M▲ 0%
2.57M▲ 148.0%
11.9M▲ 363.0%
14.87M▲ 25.0%
21.02M▲ 41.4%
12.82M▼ 39.0%
10.87M▼ 15.3%
22.49M▲ 0%
Gross Margin %
46.93%34.67%49.38%64.47%57.68%49.32%68.74%86.04%
Gross Profit Growth %
-148.02%363%24.97%41.36%-38.99%-15.26%-
Operating Expenses
1.63M7.41M10.47M21.36M33.3M35.29M23.37M-25.24M
OpEx % of Revenue
73.61%99.94%43.46%92.6%91.38%135.72%147.79%-
Selling, General & Admin
1.63M7.41M9.44M19.8M26.07M22.54M22.99M48.1M
SG&A % of Revenue
73.61%99.94%39.19%85.86%71.55%86.7%145.37%-
Research & Development
00000000
R&D % of Revenue
--------
Other Operating Expenses
001.03M1.55M7.23M12.74M382.29K-69.54K
Operating Income
-589.05K▲ 0%
-4.84M▼ 721.4%
1.43M▲ 129.5%
-6.49M▼ 554.8%
-12.28M▼ 89.3%
-22.46M▼ 82.9%
-12.5M▲ 44.4%
47.73M▲ 0%
Operating Margin %
-26.68%-65.27%5.92%-28.13%-33.7%-86.39%-79.06%182.6%
Operating Income Growth %
--721.37%129.49%-554.82%-89.25%-82.91%44.35%-
EBITDA
-521.49K-4.23M2.46M-3.76M-8.8M-18.78M-11.74M48.18M
EBITDA Margin %
-23.62%-57.02%10.2%-16.28%-24.15%-72.24%-74.26%184.35%
EBITDA Growth %
--710.57%158.12%-252.87%-134.28%-113.48%37.49%338.67%
D&A (Non-Cash Add-back)
67.57K611.35K1.03M2.73M3.48M3.68M757.76K457.35K
EBIT
-589.05K-4.84M1.43M-6.49M-8.53M-13.4M-12.88M47.91M
Net Interest Income
3.07K-138.41K-530.45K-202.12K-4.72M-3.12M-1.17M-10.4M
Interest Income
3.07K0000000
Interest Expense
0138.41K530.45K202.12K4.72M3.12M1.17M10.4M
Other Income/Expense
2.01K-546.54K269.4K101.08K-4.68M-3.14M-1.18M-276.17M
Pretax Income
-587.04K▲ 0%
-5.38M▼ 817.3%
1.7M▲ 131.5%
-6.39M▼ 476.6%
-16.96M▼ 165.4%
-25.6M▼ 51.0%
-13.68M▲ 46.6%
-228.45M▲ 0%
Pretax Margin %
-26.59%-72.64%7.04%-27.7%-46.53%-98.47%-86.55%-874.01%
Income Tax
00-1.28M-518.4K-3.05M-332.1K00
Effective Tax Rate %
0%0%-75.63%8.12%17.98%1.3%0%0%
Net Income
-587.04K▲ 0%
-5.38M▼ 817.1%
2.98M▲ 155.3%
-2.1M▼ 170.5%
-16.93M▼ 705.9%
-23.66M▼ 39.7%
-13.68M▲ 42.2%
-228.45M▲ 0%
Net Margin %
-26.59%-72.63%12.36%-9.11%-46.46%-90.99%-86.55%-874.01%
Net Income Growth %
--817.09%155.33%-170.52%-705.88%-39.74%42.16%-915.13%
Net Income (Continuing)
-587.04K-5.38M2.98M-5.87M-13.91M-25.27M-13.68M-228.45M
Discontinued Operations
0003.82M-1.37M1.16M00
Minority Interest
1.66M1.95M054.82K-505.15K000
EPS (Diluted)
-0.04▲ 0%
-0.41▼ 919.9%
4.20▲ 1124.4%
-0.13▼ 103.1%
-16.46▼ 12561.5%
-24.16▼ 46.8%
-1.73▲ 92.8%
-3.49▲ 0%
EPS Growth %
--919.9%1124.39%-103.1%-12561.54%-46.78%92.84%80.42%
EPS (Basic)
-0.04-0.415.00-0.13-16.46-24.16-1.73-
Diluted Shares Outstanding
14.54M14.54M712.9K16.22M17.88M1.03M7.91M65.51M
Basic Shares Outstanding
14.54M14.54M596.52K16.22M17.88M1.03M7.91M65.51M
Dividend Payout Ratio
--------

UPXI Balance Sheet

Upexi, Inc. (UPXI) balance sheet — assets, liabilities & shareholders' equity

MetricJun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Total Current Assets
5.12M2.65M18.29M17.06M30.01M11.42M56.78M121.8M
Cash & Short-Term Investments
3.7M887.52K14.53M7.15M4.49M661.41K2.98M118.43M
Cash Only
3.7M887.52K14.53M7.15M4.49M661.41K2.98M3.48M
Short-Term Investments
0000000114.94M
Accounts Receivable
147.72K165.15K1.28M2.16M2.12M4.82M2.39M2.18M
Days Sales Outstanding
24.428.1319.3534.121.1967.6655.2135.73
Inventory
1.14M1.45M2.09M6.45M4.8M1.43M1.15M215.24K
Days Inventory Outstanding
354.48109.1762.7287.45113.7139.6685.1278.32
Other Current Assets
00167.67K1.09M18.1M4.07M49.91M0
Total Non-Current Assets
2.39M3.75M8.96M31.43M33.79M12.09M67.03M78.57M
Property, Plant & Equipment
262.01K1.98M3.25M8.97M3.24M4.78M3.79M952.28K
Fixed Asset Turnover
8.43x3.74x7.41x2.57x11.24x5.44x4.17x10.66x
Goodwill
493.1K493.1K2.41M8.3M2.89M848.85K848.85K673.85K
Intangible Assets
1.63M1.24M1.85M12.05M6.92M239.87K163.11K70.82M
Long-Term Investments
0000000750K
Other Non-Current Assets
-2.39M37.07K49.07K100.37K15.13M278.44K56.28M178.59K
Total Assets
7.5M▲ 0%
6.4M▼ 14.7%
27.25M▲ 325.7%
48.49M▲ 77.9%
63.8M▲ 31.6%
23.51M▼ 63.1%
123.81M▲ 426.6%
200.37M▲ 0%
Asset Turnover
0.29x1.16x0.88x0.48x0.57x1.11x0.13x0.10x
Asset Growth %
--14.68%325.71%77.92%31.57%-63.15%426.59%5259.49%
Total Current Liabilities
1.11M3.52M5.82M10.13M22.39M12.66M32.56M70.82M
Accounts Payable
271.06K484.33K1.6M1.57M1.03M481.65K1.04M288.72K
Days Payables Outstanding
84.4336.548.0370.0224.3513.3476.74104.5
Short-Term Debt
01.68M447.1K5.69M12.32M8.08M25.94M61.33M
Deferred Revenue (Current)
255.63K473.32K485.97K335.2K0235.25K13.15K114.11K
Other Current Liabilities
486.62K221.66K2.06M1.79M5.35M1.2M3.47M4.7M
Current Ratio
4.62x0.75x3.14x1.68x1.34x0.90x1.74x1.72x
Quick Ratio
3.59x0.34x2.78x1.05x1.13x0.79x1.71x1.72x
Cash Conversion Cycle
294.4780.834.03251.53110.5593.9763.599.55
Total Non-Current Liabilities
0703.39K217.43K9.58M13.57M4.34M1.15M181.47M
Long-Term Debt
0365.35K08.88M13.57M2.61M0181.03M
Capital Lease Obligations
0338.04K217.43K700.41K01.73M1.15M3.19M
Deferred Tax Liabilities
00000000
Other Non-Current Liabilities
00000000
Total Liabilities
1.11M4.22M6.04M19.7M35.96M17M33.71M252.29M
Total Debt
02.85M864.06K15.45M26.34M13.45M27.78M242.8M
Net Debt
-3.7M1.96M-13.67M8.3M21.85M12.79M24.8M239.32M
Debt / Equity
-1.31x0.04x0.54x0.95x2.06x0.31x-4.68x
Debt / EBITDA
--0.35x----5.04x
Net Debt / EBITDA
---5.56x----4.97x
Interest Coverage
--34.96x2.69x-32.11x-1.81x-4.29x-10.97x4.61x
Total Equity
6.4M▲ 0%
2.18M▼ 65.9%
21.22M▲ 873.6%
28.79M▲ 35.7%
27.84M▼ 3.3%
6.52M▼ 76.6%
90.1M▲ 1282.7%
-51.92M▲ 0%
Equity Growth %
--65.93%873.58%35.67%-3.3%-76.59%1282.73%3661.43%
Book Value per Share
0.440.1529.761.771.566.3411.38-0.79
Total Shareholders' Equity
4.74M225.58K21.22M28.73M28.34M6.52M90.1M-51.92M
Common Stock
9.65K10.22K15.26K16.71K1.01K11383669
Retained Earnings
-1.72M-7.1M-4.17M-6.27M-23.2M-46.86M-60.54M-282.06M
Treasury Stock
00000000
Accumulated OCI
00000000
Minority Interest
1.66M1.95M054.82K-505.15K000

UPXI Cash Flow Statement

Upexi, Inc. (UPXI) cash flow — operating, investing & free cash flow history

MetricJun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Cash from Operations
-1.19M-4.16M2.94M521.87K202.68K-101.38K-8.42M-21.52M
Operating CF Margin %
-54.09%-56.18%12.2%2.26%0.56%-0.39%-53.27%-
Operating CF Growth %
--248.68%170.58%-82.25%-61.16%-150.02%-8208.63%-1095.19%
Net Income
-587.04K-5.38M2.98M-2.1M-16.93M-25.27M-13.68M-228.45M
Depreciation & Amortization
67.57K611.35K1.03M2.73M3.54M3.68M757.76K457.35K
Stock-Based Compensation
604.56K372.77K611.43K3.33M3.66M02.11M15.47M
Deferred Taxes
00-1.28M-1.06M0-344.8K00
Other Non-Cash Items
11.78K568.88K123.65K924.9K11.36M18.94M465.19K186.38M
Working Capital Changes
-1.29M-334.06K-521.93K-3.31M-1.44M2.89M1.93M4.62M
Change in Receivables
-54.47K-250.16K-1.14M-17.31K-364.67K675.71K-484.58K-695.19K
Change in Inventory
-620.37K-310.38K-846.66K-2.45M-1.37M2.65M-470.19K860.35K
Change in Payables
-665.66K277.98K1.97M-430.51K0-944.02K2.87M5.52M
Cash from Investing
-1.67M-1.46M-1.28M-11.61M-2.57M-3.38M-99.29M-134M
Capital Expenditures
-219.45K-1.93M-1.42M-6.15M-937.56K-932.57K-387.76K-201.49K
CapEx % of Revenue
9.94%26.02%5.9%26.68%2.57%3.59%2.45%0.77%
Acquisitions
-1.45M062.12K-5.46M-4.58M1.56M6.01M660K
Investments
--------
Other Investing
0466.11K79K6K2.94M-4M0-607.28K
Cash from Financing
6.46M2.82M11.99M3.7M-285.33K-353.79K110.03M158.78M
Debt Issued (Net)
02.05M988.08K5.68M-1.56M-353.79K16.9M13.32M
Equity Issued (Net)
4.67M470K11M-1.98M0093.13M153.09M
Dividends Paid
00000000
Share Repurchases
000-1.98M000-2.77M
Other Financing
1.79M298.8K001.28M00-7.63M
Net Change in Cash
3.6M▲ 0%
-2.81M▼ 178.1%
13.65M▲ 585.7%
-7.38M▼ 154.1%
-2.66M▲ 64.0%
-3.83M▼ 44.2%
2.31M▲ 160.4%
3.25M▲ 0%
Free Cash Flow
-1.41M▲ 0%
-6.09M▼ 331.0%
1.52M▲ 124.9%
-5.63M▼ 471.3%
-734.89K▲ 87.0%
-1.03M▼ 40.7%
-8.81M▼ 752.2%
-21.73M▲ 0%
FCF Margin %
-64.03%-82.21%6.3%-24.42%-2.02%-3.98%-55.72%-83.12%
FCF Growth %
--330.99%124.9%-471.26%86.95%-40.69%-752.16%-1052.48%
FCF per Share
-0.10-0.422.13-0.35-0.04-1.01-1.11-0.33
FCF Conversion (FCF/Net Income)
2.03x0.77x0.99x-0.25x-0.01x0.00x0.62x0.10x
Interest Paid
02.52K064.46K2.28M000
Taxes Paid
000656K0000

UPXI Key Ratios

Upexi, Inc. (UPXI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric202020212022202320242025TTM
Return on Equity (ROE)
-125.55%25.46%-8.4%-59.8%-137.74%-28.33%-306.96%
Return on Invested Capital (ROIC)
-106.12%18.31%-21.81%-21.23%-48.83%-13.97%14.74%
Gross Margin
34.67%49.38%64.47%57.68%49.32%68.74%86.04%
Net Margin
-72.63%12.36%-9.11%-46.46%-90.99%-86.55%-874.01%
Debt / Equity
1.31x0.04x0.54x0.95x2.06x0.31x-4.68x
Interest Coverage
-34.96x2.69x-32.11x-1.81x-4.29x-10.97x4.61x
FCF Conversion
0.77x0.99x-0.25x-0.01x0.00x0.62x0.10x
Revenue Growth
235.72%225.04%-4.27%57.99%-28.65%-39.19%218.47%
Related:UPXI Dividend History·UPXI Revenue History·UPXI Price History·UPXI P/E History·UPXI Financial Ratios·UPXI Institutional Holders

UPXI SEC Filings & Documents

Upexi, Inc. (UPXI) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 13, 2026·SEC

Material company update

May 7, 2026·SEC

Material company update

Mar 31, 2026·SEC

10-K Annual Reports

1
FY 2025

Sep 24, 2025·SEC

10-Q Quarterly Reports

3
FY 2026

May 12, 2026·SEC

FY 2026

Feb 10, 2026·SEC

FY 2025

Nov 12, 2025·SEC

UPXI Frequently Asked Questions

Upexi, Inc. (UPXI) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Upexi, Inc. (UPXI) reported $26.1M in revenue for fiscal year 2025. This represents a 1084% increase from $2.2M in 2019.

Upexi, Inc. (UPXI) saw revenue decline by 39.2% over the past year.

Upexi, Inc. (UPXI) reported a net loss of $228.4M for fiscal year 2025.

Dividend & Returns

Upexi, Inc. (UPXI) has a return on equity (ROE) of -28.3%. Negative ROE indicates the company is unprofitable.

Upexi, Inc. (UPXI) had negative free cash flow of $21.7M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in UPXI back in 2019?

Total return calculator · dividends reinvested · 7+ years of data

See returns →

How much would $100/month in UPXI be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →